Oculis Holding AG
OCSAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; no superinvestor holds it.
Other share classesOCS
Q2 2026 vs. Q1 2026
How the institutions holding Oculis Holding AG changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| Shares | 220.7K | 231.2K | +10.5K (+4.8%) |
| Value | $2.91M | $1.16M | −$1.76M (−60.3%) |
New holders (1)
Institutions that held Oculis Holding AG at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| LMR Partners LLP | 39,949 | $199.7K | 0.00% |
Sold out (1)
Institutions that held Oculis Holding AG at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Wolverine Asset Management LLC | 7,774 | $101.1K |